PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $50,000 | -23.1% | 7,106 | 0.0% | 0.00% | – |
Q2 2021 | $65,000 | -5.8% | 7,106 | 0.0% | 0.00% | – |
Q1 2021 | $69,000 | -5.5% | 7,106 | 0.0% | 0.00% | – |
Q4 2020 | $73,000 | +1.4% | 7,106 | 0.0% | 0.00% | – |
Q3 2020 | $72,000 | -2.7% | 7,106 | 0.0% | 0.00% | – |
Q2 2020 | $74,000 | +23.3% | 7,106 | 0.0% | 0.00% | – |
Q1 2020 | $60,000 | +13.2% | 7,106 | +16.8% | 0.00% | – |
Q4 2019 | $53,000 | -19.7% | 6,086 | 0.0% | 0.00% | – |
Q3 2019 | $66,000 | -14.3% | 6,086 | 0.0% | 0.00% | – |
Q2 2019 | $77,000 | -67.4% | 6,086 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $236,000 | +90.3% | 6,086 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $124,000 | -55.6% | 6,086 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $279,000 | -22.5% | 6,086 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $360,000 | -13.0% | 6,086 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $414,000 | -35.3% | 6,086 | -5.9% | 0.00% | -25.0% |
Q4 2017 | $640,000 | -17.4% | 6,471 | 0.0% | 0.00% | -33.3% |
Q3 2017 | $775,000 | +36.9% | 6,471 | 0.0% | 0.01% | +50.0% |
Q2 2017 | $566,000 | +134.9% | 6,471 | 0.0% | 0.00% | +100.0% |
Q1 2017 | $241,000 | +21.1% | 6,471 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $199,000 | -54.1% | 6,471 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $434,000 | +124.9% | 6,471 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $193,000 | -9.8% | 6,471 | -11.0% | 0.00% | 0.0% |
Q1 2016 | $214,000 | -62.5% | 7,274 | -0.0% | 0.00% | -60.0% |
Q4 2015 | $570,000 | +4.0% | 7,275 | +0.1% | 0.01% | 0.0% |
Q3 2015 | $548,000 | -35.5% | 7,268 | -0.1% | 0.01% | -28.6% |
Q2 2015 | $850,000 | -44.4% | 7,277 | +12.5% | 0.01% | -46.2% |
Q1 2015 | $1,528,000 | +24.7% | 6,471 | 0.0% | 0.01% | +30.0% |
Q4 2014 | $1,225,000 | -20.7% | 6,471 | 0.0% | 0.01% | -23.1% |
Q3 2014 | $1,544,000 | +119.6% | 6,471 | -39.2% | 0.01% | +116.7% |
Q2 2014 | $703,000 | – | 10,651 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |